OBJECTIVE: The aim of this systematic review was to evaluate existing literature on inflammatory markers in CSF from patients with hydrocephalus and identify potential markers capable of promoting hydrocephalus development and progression. METHODS: Relevant studies published before December 3rd 2020 were identified from PubMed, Embase, and reference lists. Studies were screened for eligibility using the predefined inclusion and exclusion criteria. Data from eligible studies were extracted, and sources of bias were evaluated. We included articles written in English investigating inflammatory markers in CSF from patients with hydrocephalus and control subjects. The review was conducted according to the PRISMA guidelines by three independent reviewers. RESULTS: Twenty-two studies analyzed CSF from 311 patients with idiopathic normal pressure hydrocephalus (iNPH), 178 with posthemorrhagic hydrocephalus (PHH), 151 with other hydrocephalus diagnoses, and 394 control subjects. Fifty-eight inflammatory markers were investigated. The CSF of iNPH patients had increased CSF levels of IL-6, IL-1β, and LRG compared with control subjects, whereas the CSF of PHH patients had increased levels of IL-6, IL-18, and VEGF. CSF from patients with "other hydrocephalus diagnoses" had elevated IFN-γ compared to control subjects, and VEGF was increased in congenital hydrocephalus, spina bifida, and hydrocephalus associated with tuberculous meningitis compared with controls. CONCLUSION: IL-6, IL-1β, LRG, IL-18, VEGF, and IFN-γ are elevated in CSF from patients with hydrocephalus and may be involved in promotion of hydrocephalus development and progression. They may serve as novel disease biomarkers, and their signaling pathways may represent targets for pharmacological management of hydrocephalus.
OBJECTIVE: The aim of this systematic review was to evaluate existing literature on inflammatory markers in CSF from patients with hydrocephalus and identify potential markers capable of promoting hydrocephalus development and progression. METHODS: Relevant studies published before December 3rd 2020 were identified from PubMed, Embase, and reference lists. Studies were screened for eligibility using the predefined inclusion and exclusion criteria. Data from eligible studies were extracted, and sources of bias were evaluated. We included articles written in English investigating inflammatory markers in CSF from patients with hydrocephalus and control subjects. The review was conducted according to the PRISMA guidelines by three independent reviewers. RESULTS: Twenty-two studies analyzed CSF from 311 patients with idiopathic normal pressure hydrocephalus (iNPH), 178 with posthemorrhagic hydrocephalus (PHH), 151 with other hydrocephalus diagnoses, and 394 control subjects. Fifty-eight inflammatory markers were investigated. The CSF of iNPH patients had increased CSF levels of IL-6, IL-1β, and LRG compared with control subjects, whereas the CSF of PHH patients had increased levels of IL-6, IL-18, and VEGF. CSF from patients with "other hydrocephalus diagnoses" had elevated IFN-γ compared to control subjects, and VEGF was increased in congenital hydrocephalus, spina bifida, and hydrocephalus associated with tuberculous meningitis compared with controls. CONCLUSION: IL-6, IL-1β, LRG, IL-18, VEGF, and IFN-γ are elevated in CSF from patients with hydrocephalus and may be involved in promotion of hydrocephalus development and progression. They may serve as novel disease biomarkers, and their signaling pathways may represent targets for pharmacological management of hydrocephalus.
Authors: Felipe A Lisboa; Matthew J Bradley; Matthew T Hueman; Seth A Schobel; Beverly J Gaucher; Edda L Styrmisdottir; Benjamin K Potter; Jonathan A Forsberg; Eric A Elster Journal: Surgery Date: 2016-12-03 Impact factor: 3.982
Authors: Bartosz Sokół; Norbert Wąsik; Roman Jankowski; Marcin Hołysz; Witold Mańko; Robert Juszkat; Tomasz Małkiewicz; Paweł P Jagodziński Journal: Biomed Res Int Date: 2017-05-29 Impact factor: 3.411
Authors: Ursula K Rohlwink; Katya Mauff; Katalin A Wilkinson; Nico Enslin; Emmanuel Wegoye; Robert J Wilkinson; Anthony A Figaji Journal: Clin Infect Dis Date: 2017-10-15 Impact factor: 9.079
Authors: Sadid F Khan; Thornton Macauley; Steven Y C Tong; Ouli Xie; Carly Hughes; Nicholas D P Hall; Siddhartha Mahanty; Ian Jennens; Alan C Street Journal: Open Forum Infect Dis Date: 2019-07-01 Impact factor: 3.835
Authors: Sara Diana Lolansen; Nina Rostgaard; Dagne Barbuskaite; Tenna Capion; Markus Harboe Olsen; Nicolas H Norager; Frederik Vilhardt; Søren Norge Andreassen; Trine L Toft-Bertelsen; Fenghui Ye; Marianne Juhler; Richard F Keep; Nanna MacAulay Journal: Fluids Barriers CNS Date: 2022-08-10
Authors: Carlotta Camilli; Alexandra E Hoeh; Giulia De Rossi; Stephen E Moss; John Greenwood Journal: J Biomed Sci Date: 2022-01-21 Impact factor: 12.771